Lori Solomon is a writer at various publications including HealthDay News and United Press International. Based in Atlanta, she specializes in health policy, public health, and medicine, covering a range of topics such as mental health care, nutrition, and fitness. Her work has been featured in outlets like the Lincoln Journal Star and Medical Xpress.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Lori's articles predominantly focus on health-related topics, with a strong emphasis on citing data and scientific research. She would likely be interested in receiving pitches from experts who can provide insights or commentary based on robust data and evidence within the healthcare, medical research, children’s health, mental health, exercise or environmental health fields.
Given Lori's reliance on data-driven content and press releases as part of her coverage attributes, she may prefer sources that can offer access to new research findings or studies related to these areas. Additionally, professionals with expertise in public health policy or those involved in groundbreaking scientific discoveries could capture her attention.
It is important for potential contributors to note that Lori does not have a specified geographic focus but instead seems to cover global developments within the realm of healthcare and medical research.
This information evolves through artificial intelligence and human feedback. Improve this profile .
90 to 119 minutes/week of strength training tied to 13 percent lower risk for death from any cause
By: Lori Solomon
THURSDAY, June 4, 2026 (HealthDay News) -- The U.S. Food and Drug Administration has approved Hepcludex (bulevirtide-gmod) injection to treat chronic hepatitis
By: Lori Solomon
FRIDAY, June 5, 2026 (HealthDay News) -- A five-minute session of proximal intercessory prayer (PIP) significantly reduces pain and anxiety in primary care pati
By: Postacute Sequelae, Elana Gotkine, Lori Solomon
We use cookies on our site to enhance your user experience, provide personalized content, and analyze our traffic. Cookie Policy.
The U.S. Food and Drug Administration has approved Shionogi's Xocova (ensitrelvir), an oral antiviral, for postexposure prophylaxis (PEP) of COVID‑19 in adults and adolescents aged 12 years and older.
We appreciate you here at HealthDay. Please sign up for unlimited health news!
Improvements seen as early as the first year and are sustained over 20 years with maintained weight loss
TUESDAY, June 9, 2026 (HealthDay News) -- Women with primary infertility have an increased risk for early menopause, according to a study published online June
TUESDAY, June 9, 2026 (HealthDay News) -- Those who prefer to go to sleep later report poorer mental health, which is partially explained by greater reported lo
By: Lori Solomon
TUESDAY, June 9, 2026 (HealthDay News) -- Two drinks per day is associated with a substantially elevated risk for a premature death caused by alcohol, according
